Spain to donate 5%-10% of its share of COVID-19 shots to Latin America
Spain will offer between 5% and 10% of its COVID-19 vaccine shots to Latin American and Caribbean countries this year, Prime Minister Pedro Sanchez said on Wednesday.
Related Articles
German watchdog approves Novo’s acquisition of Cardior Pharmaceuticals
The German cartel office has approved a deal by Denmark’s Novo Nordisk to purchase Cardior Pharmaceuticals, the regulator said in a statement on Thursday.
Weight-loss drug developer Metsera raises $290 million in funding
Weight-loss drug developer Metsera has raised $290 million in funding, led by biotech investor ARCH Venture Partners as well as participation from firms such as…
Cerevel Therapeutics’ Parkinson’s disease drug meets main goal in late-stage study
Cerevel Therapeutics said on Thursday its Parkinson’s disease drug met the main goal of a late-stage trial.
Elevance beats first-quarter profit estimates on higher premiums
Elevance Health beat Wall Street estimates for first-quarter profit on Thursday, as higher premiums in its commercial insurance business helped keep medical costs for the…
German watchdog approves Novo’s acquisition of Cardior Pharmaceuticals
The German cartel office has approved a deal by Denmark’s Novo Nordisk to purchase Cardior Pharmaceuticals, the regulator said in a statement on Thursday.
23andMe CEO Wojcicki considering taking firm private, filing shows
23andMe co-founder and chief executive Anne Wojcicki is considering making an offer to buy the genetics testing company in a potential go-private transaction, a regulatory…
FDA classifies recall of Boston Scientific device as ‘most serious’
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific’s device used to block blood flow during excessive bleeding or hemorrhaging…
23andMe CEO Wojcicki considering taking firm private, filing shows
23andMe co-founder and chief executive Anne Wojcicki is considering making an offer to buy the genetics testing company in a potential go-private transaction, a regulatory…
FDA classifies recall of Boston Scientific device as ‘most serious’
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific’s device used to block blood flow during excessive bleeding or hemorrhaging…
Abbott’s device sales drive profit beat, but shares fall as forecast disappoints
Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday on robust sales of its medical devices, but the company’s stock fell 3% in…